| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |